Literature DB >> 27012595

Challenges of metabolomics in human gut microbiota research.

Kirill S Smirnov1, Tanja V Maier1, Alesia Walker1, Silke S Heinzmann1, Sara Forcisi1, Inés Martinez2, Jens Walter2, Philippe Schmitt-Kopplin3.   

Abstract

The review highlights the role of metabolomics in studying human gut microbial metabolism. Microbial communities in our gut exert a multitude of functions with huge impact on human health and disease. Within the meta-omics discipline, gut microbiome is studied by (meta)genomics, (meta)transcriptomics, (meta)proteomics and metabolomics. The goal of metabolomics research applied to fecal samples is to perform their metabolic profiling, to quantify compounds and classes of interest, to characterize small molecules produced by gut microbes. Nuclear magnetic resonance spectroscopy and mass spectrometry are main technologies that are applied in fecal metabolomics. Metabolomics studies have been increasingly used in gut microbiota related research regarding health and disease with main focus on understanding inflammatory bowel diseases. The elucidated metabolites in this field are summarized in this review. We also addressed the main challenges of metabolomics in current and future gut microbiota research. The first challenge reflects the need of adequate analytical tools and pipelines, including sample handling, selection of appropriate equipment, and statistical evaluation to enable meaningful biological interpretation. The second challenge is related to the choice of the right animal model for studies on gut microbiota. We exemplified this using NMR spectroscopy for the investigation of cross-species comparison of fecal metabolite profiles. Finally, we present the problem of variability of human gut microbiota and metabolome that has important consequences on the concepts of personalized nutrition and medicine.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Gut microbiota; IBD; Mass spectrometry; Metabolomics; NMR

Mesh:

Year:  2016        PMID: 27012595     DOI: 10.1016/j.ijmm.2016.03.006

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  30 in total

1.  Metabolomics technology and bioinformatics for precision medicine.

Authors:  Rajeev K Azad; Vladimir Shulaev
Journal:  Brief Bioinform       Date:  2019-11-27       Impact factor: 11.622

Review 2.  Complementary Methodologies To Investigate Human Gut Microbiota in Host Health, Working towards Integrative Systems Biology.

Authors:  Manuel Ferrer; David Rojo; Celia Méndez-García; Coral Barbas
Journal:  J Bacteriol       Date:  2018-01-10       Impact factor: 3.490

Review 3.  Methods in microbiome research: Past, present, and future.

Authors:  Emily C Gotschlich; Robert A Colbert; Tejpal Gill
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-04-24       Impact factor: 4.098

Review 4.  Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.

Authors:  R Balfour Sartor; Gary D Wu
Journal:  Gastroenterology       Date:  2016-10-18       Impact factor: 22.682

Review 5.  Symbiosis-inspired approaches to antibiotic discovery.

Authors:  Navid Adnani; Scott R Rajski; Tim S Bugni
Journal:  Nat Prod Rep       Date:  2017-07-06       Impact factor: 13.423

Review 6.  The gut microbiota and inflammatory bowel diseases.

Authors:  Jun Miyoshi; Eugene B Chang
Journal:  Transl Res       Date:  2016-06-14       Impact factor: 7.012

Review 7.  The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives.

Authors:  Christophe d'Enfert; Ann-Kristin Kaune; Leovigildo-Rey Alaban; Sayoni Chakraborty; Nathaniel Cole; Margot Delavy; Daria Kosmala; Benoît Marsaux; Ricardo Fróis-Martins; Moran Morelli; Diletta Rosati; Marisa Valentine; Zixuan Xie; Yoan Emritloll; Peter A Warn; Frédéric Bequet; Marie-Elisabeth Bougnoux; Stephanie Bornes; Mark S Gresnigt; Bernhard Hube; Ilse D Jacobsen; Mélanie Legrand; Salomé Leibundgut-Landmann; Chaysavanh Manichanh; Carol A Munro; Mihai G Netea; Karla Queiroz; Karine Roget; Vincent Thomas; Claudia Thoral; Pieter Van den Abbeele; Alan W Walker; Alistair J P Brown
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

8.  Using nontargeted LC-MS metabolomics to identify the Association of Biomarkers in pig feces with feed efficiency.

Authors:  Jie Wu; Yong Ye; Jianping Quan; Rongrong Ding; Xingwang Wang; Zhanwei Zhuang; Shenping Zhou; Qian Geng; Cineng Xu; Linjun Hong; Zheng Xu; Enqin Zheng; Gengyuan Cai; Zhenfang Wu; Jie Yang
Journal:  Porcine Health Manag       Date:  2021-06-02

9.  Towards Standards for Human Fecal Sample Preparation in Targeted and Untargeted LC-HRMS Studies.

Authors:  Farideh Hosseinkhani; Anne-Charlotte Dubbelman; Naama Karu; Amy C Harms; Thomas Hankemeier
Journal:  Metabolites       Date:  2021-06-07

Review 10.  Using Metabolomic Profiles as Biomarkers for Insulin Resistance in Childhood Obesity: A Systematic Review.

Authors:  Xue Zhao; Xiaokun Gang; Yujia Liu; Chenglin Sun; Qing Han; Guixia Wang
Journal:  J Diabetes Res       Date:  2016-07-19       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.